La melatonina como tratamiento alternativo en tiempos de pandemia por COVID-19
DOI:
https://doi.org/10.47230/unesum-salud.v1.n1.2022.35-40Palabras clave:
N-acetil-5-metoxiptriptamina, efecto antiviral, antiinflamación, antioxidants, COVID-19Resumen
La melatonina o N-acetil-5-metoxiptriptamina es una hormona sintetizada a partir del aminoácido esencial triptófano fundamentalmente por las células de la glándula pineal. Las funciones de la melatonina son muy variadas y muchas de ellas todavía poco conocidas. Se ha estudiado ampliamente su efecto antioxidante, antiinflamatorio y antiviral en diferentes modelos biológicos tanto in vitro como en modelos animales. En esta mini revisión se dan a conocer las experiencias con el uso de la melatonina y se destaca s potencial uso terapeutico durante la pandemia de COVID-19 y el tratamiento de las secuelas ya ampliamente descritas.
Descargas
Citas
Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis [Internet]. 2020 [Publication in advance]. Disponible en: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30120-1/fulltext. DOI: 10.1016/S14733099(20)30120-1
Valero-Cedeño NJ, Mina-Ortiz JB, Veliz-Castro TI, Merchán Villafuerte KM, Perozo-Mena AJ. COVID-19: La nueva pandemia con muchas lecciones y nuevos retos. Kasmera. 2020; 48(1): e48102042020. doi:10.5281/zenodo.3745322
Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020. doi: 10.1002/jmv.25728.
Yang N, Shen HM. Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19. Int J Biol Sci. 2020;16(10):1724-1731. doi: 10.7150/ijbs.45498. eCollection 2020.
Ben-Nathan D, Maestroni GJ, Lustig S, Conti A. Protective effects of melatonin in mice infected with encephalitis viruses. Arch Virol. 1995; 140(2):223-30.
Bonilla E, Valero N, Pons H, Chacín-Bonilla L. Melatonin protects mice infected with Venezuelan equine encephalomyelitis virus. Cell Mol Life Sci. 1997; 53(5):430-4.
Montiel M, Bonilla E, Valero N, Mosquera J, Espina LM, Quiroz Y, Álvarez-Mon M. Melatonin decreases brain apoptosis, oxidative stress, and CD200 expression and increased survival rate in mice infected by Venezuelan equine encephalitis virus. Antivir Chem Chemother. 2015; 24(3-4):99-108.
Valero N, Mosquera J, Alcocer S, Bonilla E, Salazar J, Álvarez-Mon M. Melatonin, minocycline and ascorbic acid reduce oxidative stress and viral titers and increase survival rate in experimental Venezuelan equine encephalitis. Brain Res. 2015; 1622:368-76. doi: 10.1016/j.brainres.2015.06.034.
Bonilla E, Valero N, Chacín‐Bonilla L, Medina‐Leendertz S. Melatonin and viral infections. J Pineal Res. 2004 Mar;36(2):73-79.
Huang SH, Cao XJ, Liu W, Shi XY, Wei W. Inhibitory effect of melatonin on lung oxidative stress induced by respiratory syncytial virus infection in mice. J Pineal Res. 2010; 48:109–116. doi: 10.1111/j.1600-079X.2009.00733.x.
Tan DX, Korkmaz A, Reiter RJ, Manchester LC. Ebola virus disease: potential use of melatonin as a treatment. J Pineal Res. 2014; 57:381–384. doi: 10.1111/jpi.12186.
Paemanee A, Hitakarun A, Roytrakul S, Smith D. Screening of melatonin, α-tocopherol, folic acid, acetyl-l-carnitine and resveratrol for anti-dengue 2 virus activity. BMC Res Notes. 2018; 11: 307. doi: 10.1186/s13104-018-3417-3
Dashti-Khavidaki S, Khalili H. Considerations for statin therapy in patients with COVID-19. Pharmacotherapy. 2020. doi: 10.1002/phar.2397.
Favero G, Franceschetti L, Bonomini F, Fabrizio Rodella L, Rezzani R. Melatonin as an Anti-Inflammatory Agent Modulating Inflammasome Activation. Int J Endocrinol. 2017. https://doi.org/10.1155/2017/1835195
Zhang R, Wang X, Ni L, Di X, Ma B, Niu S, Liu C, Reiter RJ. COVID-19: Melatonin as a potential adjuvant treatment. Life Sci. 2020 Mar 23; 250:117583. doi: 10.1016/j.lfs.2020.117583.
Reiter RJ. The melatonin rhythm: both a clock and a calendar. Experientia. 1993; 49: 654–664. https://doi.org/10.1007/BF01923947
Scholtens R, van Munster B, van Kempen M, de Rooij S. Physiological melatonin levels in healthy older people: a systematic review. J Psychosom Res. 2016; 86:20-27. doi: 10.1016/j.jpsychores.2016.05.005
Karasek M, Reiter RJ. Melatonin and aging. Neuro Endocrinol Lett. 2002;23 Suppl 1:14-6. PMID: 12019345.
Hardeland R. Melatonin and the theories of aging: a critical appraisal of melatonin’s role in antiaging mechanisms. J Pineal Res. 2013; 55(4):325-56. doi: 10.1111/jpi.12090.
Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, Xiong W, Yang D, Chen R, Lu F, Lu Y, Liu X, Chen Y, Li X, Li Y, Summah HD, Lin H, Yan J, Zhou M, Lu H, Qu J. COVID-19 with Different Severity: A Multi-center Study of Clinical Features. Am J Respir Crit Care Med. 2020 Apr 10. doi: 10.1164/rccm.202002-0445OC.
Lippi G, Mattiuzzi C, Sanchis-Gomar F, Henry BM. Clinical and demographic characteristics of patients dying from COVID-19 in Italy versus China.J Med Virol. 2020. doi: 10.1002/jmv.25860.
Hasan ZT, Atrakji DMQYMAA, Mehuaiden DAK. The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients. Int J Infect Dis. 2022; 114:79-84. doi: 10.1016/j.ijid.2021.10.012. PMID: 34653660; PMCID: PMC8506572.
Mousavi SA, Heydari K, Mehravaran H, Saeedi M, Alizadeh-Navaei R, Hedayatizadeh-Omran A, Shamshirian A. Melatonin effects on sleep quality and outcomes of COVID-19 patients: An open-label, randomized, controlled trial. J Med Virol. 2022; 94(1):263-271. doi: 10.1002/jmv.27312. PMID: 34460132; PMCID: PMC8662261.
Farnoosh G, Akbariqomi M, Badri T, Bagheri M, Izadi M, Saeedi-Boroujeni A, Rezaie E, Ghaleh HEG, Aghamollaei H, Fasihi-Ramandi M, Hassanpour K, Alishiri G. Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial. Arch Med Res. 2022; 53(1):79-85. doi: 10.1016/j.arcmed.2021.06.006. PMID: 34229896; PMCID: PMC8220995.
Borges L, Gennari-Felipe M, Dias BB, Hatanaka E. Melatonin, Zinc, and Vitamin C: Potential Adjuvant Treatment for COVID-19 Patients. Front Nutr. 2022; 8:821824. doi: 10.3389/fnut.2021.821824. PMID: 35155533; PMCID: PMC8826215.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2022 Nereida Valero-Cedeño, Ernesto Bonilla Romero
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
